GSK plc

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 09:05:04 14/07/2025 pm IST			5-day change	1st Jan Change
1,424.50 ^GBX	+1.14%		+2.08%	+5.79%

15/07	European Equities Close Mixed in Monday Trading; EU Signals Readiness to Retaliate Against US Tariffs	MT
15/07	GSK-backed ViiV Healthcare Adds Injectable Cabotegravir to HIV Medicines Patent Pool License Deal	MT

GSK applies to EU regulator for expanded use of RSV vaccine

Published on 13/06/2025 at 12:07, updated on 13/06/2025 at 14:45

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about GSK plc

European Equities Close Mixed in Monday Trading; EU Signals Readiness to Retaliate Against US Tariffs	15/07	MT
GSK-backed ViiV Healthcare Adds Injectable Cabotegravir to HIV Medicines Patent Pool License Deal	15/07	MT
GSK Viiv Extends Cabotegravir Licensing Deal to Include HIV Treatment	14/07	MT
GSK seeks FDA nod for expanded use of RSV vaccine in adults	14/07	RE
Global markets live: Tesla, Gilead, Kenvue, Amazon, Bayer…	14/07
ViiV expands licence to allow generic HIV treatment production for low-income countries	14/07	RE
GSK Seeks FDA Approval to Expand RSV Vaccine Use to At-Risk Adults Aged 18-49	14/07	MT
GSK: seeks FDA approval to expand Arexvy indication	14/07	CF
GSK seeks FDA green light for expanded use of RSV vaccine Arexvy	14/07	AN
DCC sells unit; South32 warns of Mozal impairment	14/07	AN
US FDA Accepts GSK's Application to Expand Indication for RSV Vaccine	14/07	MT
GSK submits Arexvy for adults 18-49 air to FDA	14/07	RE
GSK seeks FDA nod for expanded use of RSV vaccine in adults	14/07	RE
Sector Update: Health Care Stocks Slide Friday Afternoon	11/07	MT
FTSE 100 eases from record levels amid soft GDP	11/07	AN
European Equities Traded in the US as American Depositary Receipts Drop Sharply in Friday Trading	11/07	MT
FDA May Fast Track Drug Reviews for Lower US Prices	11/07	MT
FDA May Fast Track Drug Reviews for Lower US Prices, Bloomberg Reports	11/07	MT
Sector Update: Health Care Stocks Decline Pre-Bell Friday	11/07	MT
GSK, Pfizer, Boehringer Ingelheim Win Reversal in Zantac Cancer Case	11/07	MT
Jet2 raised to 'buy'; Investec cuts Pagegroup	11/07	AN
Delaware Supreme Court sides with Zantac drugmakers over cancer evidence	11/07	RE
Sector Update: Health Care Stocks Rise Late Afternoon	11/07	MT
Delaware Supreme Court sides with Zantac drugmakers over evidence	11/07	RE
Sector Update: Health Care Stocks Rise Thursday Afternoon	10/07	MT

GSK plc is a global biopharma company. The Companyâs segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.

Employees

68,629

Sector

Pharmaceuticals

Calendar

02:15pm - International AIDS Society Conference - Abstract #OAB0104

More about the company